Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
In its effort to temper the sky-high prices Americans pay for many vital medications, the Trump administration last month unveiled a plan that would legalize the importation of selected prescription drugs from countries where they sell for far less. But the plan addresses imports only at the wholesale level; it is silent about the transactions by millions of Americans who already buy their medications outside the United States.
The head of the nation’s health insurance lobby on Wednesday said he does not see much difference between “Medicare for All,” which is being championed by progressive Democratic presidential candidates, and the public option pushed by former Vice President Joe Biden.
Medicare could have saved nearly $1 billion in 2016 if it used generic versions of pricey combination drug-device products instead of the brand name versions, according to a new study.
Leaning back on a black leather sofa as her campaign bus rumbled toward Fort Dodge, Kamala D. Harris tried to explain why she spent months defending a plan to replace private health insurance with Medicare-for-all, only to switch to a more modest proposal that would allow private insurance to continue after all.
Between 2011 and 2017, Medicare could have saved $17.7 billion if generic versions of older medicines were prescribed instead of updated brand-name drugs launched by drugmakers to replace their older off-patent pills, according to a new study published in the Annals of Internal Medicine.
Fewer large, self-insured employers will offer a high-deductible health plan as the only employee insurance option next year, opting instead to give employees more choice when it comes to health coverage.
The American Medical Association (AMA), the nation’s main group for doctors, announced Thursday that it is leaving a coalition fighting "Medicare for All," a blow to the industry’s efforts to push back on the progressive proposal.
A top Trump health administrator on Thursday said that officials are actively “working on” a plan to repeal and replace ObamaCare, which has remained a priority for President Trump even as many congressional Republicans look to move on.
If health insurers have their way, Medicare for All will be a nonstarter. And they’ve got the lobbying battle lines drawn to prove it—with pharmaceutical companies on their side.
Though support or opposition for “Medicare for All” is dominating the 2020 primary headlines, a large group of Americans is more ambivalent about the proposal, a new survey shows.